SillaJen, Inc. executed a definitive merger agreement to acquire remaining stake in Jennerex Biotherapeutics, Inc. for approximately $150 million.
Wedbush PacGrow Life Sciences acted as financial and Alan Mendelson, Luke Bergstrom, David Wheeler, Deepa Rich, Nick Palatucci, Kirt Switzer, Una Au, Jay Metz, Ashley Wagner, Judith Hasko, Kathleen Cui, Yina Dong, Ed Shapiro, John Manthei, Seth Gilmore and Amy Speros of Latham & Watkins LLP acted as legal advisor for SillaJen. Centerview Partners LLC acted as financial advisor and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP acted as legal advisor for Jennerex, Inc. Dongbu Securities Co., Ltd. (KOSE:A016610) and Korea Ratings Co., Ltd. acted as financial advisors for SillaJen. Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP acted as legal advisor to Transgene SA.